$133.24
0.57% today
NYSE, May 09, 10:00 pm CET
ISIN
US0028241000
Symbol
ABT

Abbott Laboratories Stock price

$134.00
+10.05 8.11% 1M
+17.41 14.93% 6M
+20.89 18.47% YTD
+29.06 27.69% 1Y
+26.61 24.78% 3Y
+40.30 43.01% 5Y
+86.43 181.69% 10Y
NYSE, Closing price Thu, May 08 2025
+0.05 0.04%
ISIN
US0028241000
Symbol
ABT
Sector

Key metrics

Market capitalization $233.14b
Enterprise Value $239.79b
P/E (TTM) P/E ratio 17.38
EV/FCF (TTM) EV/FCF 36.02
EV/Sales (TTM) EV/Sales 5.66
P/S ratio (TTM) P/S ratio 5.51
P/B ratio (TTM) P/B ratio 4.78
Dividend yield 1.67%
Last dividend (FY24) $2.24
Revenue growth (TTM) Revenue growth 5.00%
Revenue (TTM) Revenue $42.34b
EBIT (operating result TTM) EBIT $7.18b
Free Cash Flow (TTM) Free Cash Flow $6.66b
Cash position $6.84b
EPS (TTM) EPS $7.71
P/E forward 33.21
P/S forward 5.22
EV/Sales forward 5.37
Short interest 1.26%
Show more

Is Abbott Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,791 stocks worldwide.

Abbott Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Abbott Laboratories forecast:

19x Buy
63%
10x Hold
33%
1x Sell
3%

Analyst Opinions

30 Analysts have issued a Abbott Laboratories forecast:

Buy
63%
Hold
33%
Sell
3%

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
42,344 42,344
5% 5%
100%
- Direct Costs 20,571 20,571
3% 3%
49%
21,773 21,773
7% 7%
51%
- Selling and Administrative Expenses 8,581 8,581
10% 10%
20%
- Research and Development Expense 2,841 2,841
4% 4%
7%
10,351 10,351
7% 7%
24%
- Depreciation and Amortization 3,169 3,169
2% 2%
7%
EBIT (Operating Income) EBIT 7,182 7,182
12% 12%
17%
Net Profit 13,432 13,432
139% 139%
32%

In millions USD.

Don't miss a Thing! We will send you all news about Abbott Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Abbott Laboratories Stock News

Positive
The Motley Fool
6 days ago
Investing in excellent dividend stocks can be a great strategy to mitigate risk and boost long-term returns. Companies that can dispense regular payouts to their shareholders -- especially those that have done so for a long time -- generally have stable and steadily growing businesses that can perform relatively well even amid downturns.
Negative
Reuters
7 days ago
A federal judge on Friday said she will allow expert testimony that formula made by Abbott Laboratories and Reckitt Benckiser subsidiary Mead Johnson for premature babies can cause a fatal intestinal illness, as the companies face hundreds of lawsuits over the claims.
Neutral
PRNewsWire
8 days ago
The test, run on Abbott's portable i-STAT ® Alinity® hand-held instrument, uses whole blood to help evaluate patients 18 years of age and older with a suspected mild traumatic brain injury, or concussion, producing lab-quality results in 15 minutes The test will be used by healthcare professionals in the medical facilities at all MotoAmerica races in 2025 ABBOTT PARK, Ill., and IRVINE, Calif.
More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office United States
CEO Robert Ford
Employees 114,000
Founded 1888
Website www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today